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smoothness and improvement of actinic elastosis, skin 
colour and reduction of hyperpigmentation were seen2.
Photoaging
Chronological aging depends on the passage of time per 
se. Photoaging depends primarily on the degree of sun 
exposure and skin pigment. It is directly correlated to the 
quantity of UV rays received during the course of a life-
time. The effects of photodemage are often evident many 
years before intrinsic aging is apparent.
Photoaging affects the sun-exposed areas and is char-
acterized clinically by fi ne and coarse wrinkling, rough-
ness, dryness, laxity, teleangiectasia, loss of tensile 
strength and pigmentary changes. There is also an in-
crease in development of benign and malignant neoplasms 
on photoaged skin. 
Photoaging is a multisystem degenerative process that 
involves the skin and skin support system. The skin sup-
port system includes the bone, cartilage, and subcutane-
ous compartments, which provide the architectural sup-
Introduction
The sun emits visible light, infrared radiation, and UV 
rays. Exposure to sun with living in an oxygen-rich atmo-
sphere causes unwanted photodamage. In addition, an 
increasing number of people are exposed to artifi cial 
source of ultraviolet radiation used in industries, commer-
cial settings and leisure activities. Having a suntan has 
long been synonymous with beauty and good health in our 
culture. Individuals who have outdoor lifestyles, live in 
sunny climates, and are lightly pigmented will experience 
the greatest degree of photoaging1. 
Topical photodynamic therapy is a well-established 
procedure for the treatment of actinic keratoses, Bowen 
disease and superficial and nodular basal cell carcinomas.
Clinical experience has demonstrated that topical pho-
todynamic extensive treatment of actinic keratoses on 
sundamaged skin also produces as a positive side effect 
significant improvement of the signs of skin aging – len-
tigines, skin roughness, fi ne lines, increases in skin 
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A B S T R A C T
The intrinsic aging process of the skin in unavoidable and depends on the passage of time per se. Among harmful 
environmental factors that contribute to extrinsic aging, long-term effects of repeated exposure to ultraviolet radiation are 
the most signifi cant and are referred to as photoaging. Photoaging is directly correlated to the quantity of UV rays received 
during the course of a lifetime. Topical photodynamic therapy is well-established procedure for the treatment of actinic 
keratoses, Bowen disease and basal cell carcinomas. Clinical experience has demonstrated that extensive treatment of 
actinic keratoses on sun-damaged skin also produces as a positive side effects signifi cant improvement of the signs of skin 
aging. An improvement of lentigines, skin roughness, fi ne lines, increases in skin smoothness and improvement of actinic 
elastosis, skin colour and reduction of hyperpigmentation were seen. The reversible side effects of photodynamic therapy 
include pain, erythema, oedema, scaling and crusting, and sometimes in darker skin types post-infl ammatory hyperpig-
mentation. Photodynamic therapy is promising approach for treatment of photoinduced skin aging and takes place between 
ablative and non-ablative methods for skin rejuvenation. Effective improvement of photoaged skin, the possibility of re-
peated treatments and imitated side effects makes photodynamic therapy a promising procedure for skin rejuvenation.
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port for dermis, epidermis, and stratum corneum3. 
Subcutaneous facial fat is removed and loss probably to 
lower growth hormone levels4. The structural destruction 
and loss of dermal collagen fi ber bundles leads to wrin-
kling; irregular melanization leads to lentigines, poikilo-
derma, and melasma. In skin with long-term sun expo-
sure, the ratio of melanocyte density is approximately 
twice that of nonexposed skin5. Prominent teleangiecta-
sias lead to erythema, and loss of hydratation in stratum 
corneum leads to fi ne wrinkling.
When the skin is chronic exposure to UV rays, the 
epidermis responds with hypertrophy. The stratum cor-
neum thickens, epidermis becomes acanthotic, and there 
is progressive dysplasia with cellular atypia, and anapla-
sia. Keratinocytes are irregular with a loss of polarity. 
Melanocytes are irregular with pockets of increased and 
decreased numbers. The Langerhans cell population in 
the epidermis is reduced and that contributed to an im-
paired immune response to skin cancer6,7. The roughness 
of photoaged skin is result of combination of changes in 
stratum corneum and changes in the glycosaminoglycan 
content of the dermis. With age, there is a decrease in gly-
cosaminoglycans in the dermis. In photoaged skin there 
is paradoxical increase in glycosaminoglycans when com-
pared with intrinsically aged skin. However, there are 
de posited on the abnormal elastotic material rather than 
in the papillary dermis and that location may make them 
unavailable as a source of hydratation8. Photoaged skin 
display thickened basement membrane. Dermal changes 
in photoaged skin are reduction in collagen and precursors 
of types I and III collagen, a degeneration of elastic fi bres, 
which are replaced in time by an amorphous mass and 
chronic infl ammation with an increase in degranulated 
mast cells, macrophages, and lymphocytes9. Blood vessels 
are dilated and tortuous6. In addition, because of the dim-
inution of the collagen framework, the blood vessels are 
poorly supported; they can easy rupture, resulting in solar 
purpura.
For a photochemical reaction to occur in the skin, ul-
traviolet radiation from the sun must be absorbed by chro-
mophore, beginning a series of photochemic reactions. 
Chromophores are DNA, aromatic amino acids, 7-dehy-
drocholesterol, cytochromes, melanin and bilirubin3,10. 
These reactions can result in changes DNA, including 
oxidation of nucleic acids and modify proteins and lipids, 
resulting in changes in function. Their accumulation may 
result in skin cancer or photoaging changes1.
Photodynamic therapy 
Photodynamic therapy (PDT) involves the activation 
of a photosensitizing drug, which preferentially localizes 
to diseased skin, by irradiation with light to cause selec-
tive cytotoxic damage2. 
PDT is a two step procedure. In the fi rst step, the pho-
tosensitizer is administered to the patient, and it is al-
lowed to be taken up by the target cells. The second step 
involves the activation of the photosensitizer in the pres-
ence of oxygen with a specifi c wavelength of light directed 
toward the target tissue. Because the photosensitizer is 
preferentially absorbed by hyperproliferative tissue and 
the light source is directly targeted on the lesional tissue, 
PDT achieves dual selectivity, minimizing damage to ad-
jacent healthy structures11.
The most commonly used photosensitizers in photody-
namic therapy are 5-aminolevulinic acid (ALA) and me-
thylaminolevulinate (MAL). 
All light source with suitable spectral characteristics 
and a high output at an absorption maximum of the pho-
tosensitizer can be used for photodynamic therapy12. 
The light sources of PDT can be categorized as conven-
tional light sources and lasers. Lasers by defi nition are 
monochromatic light sources. Diode lasers (632 and 670 
nm) and pulsed dye lasers (595 nm) have been used in 
PDT. As that lasers emit coherent light, they can be fo-
cused on to even very small target areas with sharp 
boundaries and greater precision13,14. 
In the treatment of large skin lesions, noncoherent 
light sources are superior to laser systems because of their 
large illumination fi elds. Polychromatic light sources al-
low the use of different photosensitizers with different 
absorption maxima. Given the right dose of drug and light, 
noncoherent light sources appear to be effective as laser 
sources12. 
Many different light sources can be effectively used in 
PDT including those that emit blue (410 nm), yellow (595 
nm), or red (630 nm) light15. The most widely accepted 
application of ALA PDT is with blue light (410 nm)for the 
treatment of actinic keratoses. MAL PDT involves expo-
sure to 37 J/cm2 or 75 J/cm2 of red light14.
The photodynamic therapeutic process involves the 
topical application of 5-aminolevulinic acid, which is the 
precursor molecule in the heme biosynthesis pathway from 
which protoporphyrin IX is formed after several enzy-
matic reactions. Topical application of ALA penetrates the 
epidermis and is then converted to protoporphyrin IX, a 
photosensitizing molecule with preferential formation and 
accumulation in tissues known to have a high cellular 
turnover, such as tumor or photodamaged cells. When 
protoporphyrin IX is photoactivated by an appropriate 
laser or light source, reactive oxygen species are produced 
which are toxic to epidermal cells, causing cell lysis. Clin-
ically, erythema and desquamation ensue with the even-
tual appearance of smoother skin. The absorption spec-
trum of protoporphyrin IX allows for a wide range of 
electromagnetic radiation options within the visible spec-
trum15. 
Photorejuvenation
Clinical experience has demonstrated that PDT exten-
sive treatment of actinic keratoses on sun-damaged skin 
also produces as a positive side effect significant improve-
ment of the signs of skin aging. In studies on the treatment 
of actinic keratoses it was observed that after PDT not 
only did actinic keratoses regress, but that the signs of 
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skin aging also appeared markedly improved16,17. PDT can 
achieve an improvement of dyspigmentation, skin rough-
ness, fi ne lines and complexion as well as an increase in 
skin smoothness and a reduction of actinic elastosis18–22.
 A significant reduction of the epidermis thick-
ness, elastotic material and the dermal inflammatory 
infiltrate as well as an increase of collagen and procolla-
gen type I and III in the upper dermis were observed. 
Transforming growth factor beta, which stimulates 
fibroblast proliferation and thus increases collagen syn-
thesis, was significantly increased after PDT, as well as 
the transforming growth factor beta type II receptor. The 
expression of collagen- and elastin-degrading matrix me-
talloproteinases (MMP-1, -3 and MMP-12) declined in 
contrast16. The expression of p53, an early marker of epi-
dermal carcinogenesis that is not expressed in normal 
skin, was significantly reduced after PDT so PDT can 
reverse the process of carcinogenesis in photodamaged 
skin23. Histologically, a significant reduction in degree 
and extent of keratinocyte atypia, a significant increase 
in collagen content of the skin and a reduction of solar 
elastosis were observed. The increase of MMP-1 and pro-
collagen I were not significant. That result suggests that 
PDT with a reduction of keratinocyte atypia and reduced 
expression of p53 results in a reduction of the carcino-
genic potential in photodamaged skin. The significant 
increase of collagen and the reduction of solar elastosis 
explain the clinically observed skin-rejuvenating effects 
of PDT16.
Pre-treatments can increase the effi cacy of PDT both 
in curative as well as in aesthetic use. They can synergis-
tically support the treatment effect or improve penetration 
of the photosensitizer (microneedling, fractional lasers, 
chemical/ mechanical peeling). Alternatively, pre-treat-
ment with an ablative fractional laser system (CO2 or 
Er:YAG laser) can be performed. Non-ablative fractional 
laser systems do not improve penetration24. They are not 
necessary and vary depending on location, skin type/ skin 
aging type and extent of extrinsic (particularly UV in-
duced) skin damage. 
A single treatment is not always suffi cient for cosmetic 
indications. A second or third treatment at intervals of at 
least 4 weeks is recommended depending on the side ef-
fects of PDT. PDT is possible over the entire year. During 
the summer months, suffi cient sun protection must be as-
sured and in the winter, the incubation phase should be 
performed in warm rooms since low outdoor temperatures 
result in reduced enzymatic conversion of the precursors 
to protoporphyrin IX25.
Side effects
The phototoxic reactions increase in proportion to lon-
ger incubation times, higher photosensitizer concentra-
tions and light doses, with it being unclear, if more inten-
sive PDT regimes actually lead to better cosmetic results. 
The reversible side effects of PDT include pain, erythema, 
edema, scaling and crusting, in darker skin types also 
post-inflammatory hyperpigmentation26.
Pain develops quickly after the start of irradiation, 
cumulates during irradiation and decreases again over 
several hours after irradiation. The pain sensation is de-
pendent on factors such as location (most intense face and 
scalp), degree of previous sun damage, skin type, gender 
and disease present (actinic keratoses are more painful 
than basal cell carcinomas). It varies greatly individually 
and can be infl uenced25.
Conclusions
The multiple procedures are available for treatment of 
signs of skin aging (laser for treatment of vascular or pig-
mentary lesions or lasers that induce collagen neosynthe-
sis, high-energy flash lamps, surgical procedures, topical 
therapies, chemical peelings, fillers, botulinum toxin, and 
others), but these methods usually improve only one or a 
few components of skin aging. The simultaneous improve-
ment of numerous components of skin aging in combina-
tion with a therapy of possibly existing AK represents the 
PDT as a good option for skin rejuvenation.
Photodynamic therapy is promising approach for treat-
ment of photoinduced skin aging and takes place between 
ablative and non-ablative methods for skin rejuvenation. 
Effective improvement of photoaged skin, the possibility 
of repeated treatments and imitated side effects makes 
photodynamic therapy a promising procedure for skin re-
juvenation.
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FOTOREJUVENACIJA – MOGUČNOSTI PRIMJENE LOKALNE FOTODINAMSKE TERAPIJE U 
POMLAĐIVANJU KOŽE 
S A Ž E T A K
Intrinzičko ili kronološko starenje ko že je neizbježno i ovisi o prolasku vremena. Ekstrinzičko starenje nastaje uslijed 
djelovanja brojnih štetnih utjecaja okoline od kojih je dugotrajno i opetovano izlaganje ultravioletnim zrakama 
najznačajnije te uzrokuje fotostarenje kože. Fotostarenje izravno je ovisno o količini UV zračenja primljenog tijekom 
života. Lokalna primjena fotodinamske terapije je jedan od uobičajnih postupaka u liječenju aktiničkih keratoza, Bowen 
bolesti i bazocelularnog karcinoma kože. Klinička ispitivanja su pokazala da tretman aktiničkih keratoza u području 
suncem oštećene kože također dovodi do značajnog smanjenja znakova starenja kože. Dolazi do smanjenja lentiginoznih 
promjena, smanjenja hrapavosti kože, sitnih bora, poboljšanja teksture kože, smanjenja solarnih elastoza i smanjenja 
hiperpigmentacija. Nuspojave fotodinamske terapije su bol, eritem, edem, deskvamacija i erozije, a ponekad kod tamni-
jih tipova kože postupalne rezidualne hiperpigmentacije. Mjesto fotodinamske terapije u liječenju promjena nastalih 
uslijed foto starenja kože nalazi se između ablativnih i neablativnih metoda pomlađivanja. Njena učinkovitost, mogučnost 
opetovane primjene i relativno blage nuspojave čine fotodinamsku terapiju obečavajućim terapijskim postupkom za 
pomlađivanje kože.
